Dela Fuente, Alberto C.
HRN: 23 72 93 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2023
CEFTRIAXONE 1G (VIAL)
09/24/2023
10/01/2023
IV
2gm
OD
T/c Urosepsis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes